Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Raj Makkar, MD
News | Heart Failure
Redo Transcatheter Aortic Valve Replacement Proven Effective, Safe

September 5, 2023 — Cedars-Sinai investigators are leaders in the innovation and use of transcatheter aortic valve ...

Home September 05, 2023
Home
First-in-Human Study Also Showed the Return of Vasomotion in Patients Treated with the DREAMS 3G Scaffold
News | Stents Bioresorbable
BIOMAG-I Study OCT Analysis Confirmed That BIOTRONIK’s Newest Resorbable Magnesium Scaffold Resorbed at 12 Months

September 5, 2023 — New data from the BIOMAG-I first-in-human trial shed light on the vascular healing process following ...

Home September 05, 2023
Home
CASTLE-HTx trial presented in a Hot Line session at ESC Congress 2023
News | Atrial Fibrillation
Atrial Fibrillation Ablation Improves Outcomes in Patients with End-stage Heart Failure

August 31, 2023 — Atrial fibrillation ablation is associated with lower rates of death, urgent heart transplantation or ...

Home August 31, 2023
Home
ECLS-SHOCK trial presented in a Hot Line session at ESC Congress 2023
News | Cardiovascular Clinical Studies
ECLS-SHOCK Trial Reports Mortality Data for Extracorporeal Life Support

August 31, 2023 — Early extracorporeal life support (ECLS) does not improve survival in patients with acute myocardial ...

Home August 31, 2023
Home
Non-inferiority and safety of one-month DAPT with BIOTRONIK’s drug-eluting stent presented as late-breaker at ESC 2023
News | Cardiovascular Clinical Studies
12-Month-Data of BIOFLOW-DAPT Study Show Positive Results for Orsiro Mission DES With Short DAPT

August 30, 2023 — BIOFLOW-DAPT one-year-data demonstrated non-inferiority and a good safety profile for the Orsiro ...

Home August 30, 2023
Home
MULTISTARS AMI trial presented in a Hot Line session today at ESC Congress 2023
News | Cardiovascular Clinical Studies
Trial Investigates Timing of Complete Revascularization for Myocardial Infarction

August 30, 2023 — Immediate multivessel percutaneous coronary intervention (PCI) is non-inferior to staged multivessel ...

Home August 30, 2023
Home
Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding percutaneous coronary intervention (PCI), according to late breaking research presented in a Hot Line session at ESC Congress 2023
News | Optical Coherence Tomography (OCT)
Optical Coherence Tomography Non-inferior to Intravascular Ultrasound for Stent Guidance

August 29, 2023 — Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding ...

Home August 29, 2023
Home
The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online today in European Heart Journal.
News | Heart Failure
First ESC Guidelines Covering All Acute Coronary Syndromes Published

August 29, 2023 — The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online ...

Home August 29, 2023
Home
Data from the landmark ILUMIEN IV trial, the first randomized imaging trial with global representation, has the potential to change clinical practice related to stent placement
News | Optical Coherence Tomography (OCT)
Abbott Unveils Late-breaking Data Showing Intravascular Imaging Via OCT can Improve Stent Procedural Outcomes, Especially in Complex Cases

August 29, 2023 — Abbott announced late-breaking data from the first-of-its-kind ILUMIEN IV OPTIMAL PCI (ILUMIEN IV) ...

Home August 29, 2023
Home
The PROFID EHRA trial is set to answer this question in a large, multicentre, EU-funded study set to enrol the first patient this summer.
News | Implantable Cardioverter Defibrillator (ICD)
Trial Re-evaluates Routine Defibrillator Implantation After Myocardial Infarction

August 28, 2023 — Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial ...

Home August 28, 2023
Home
HEART-FID trial presented in a Hot Line session Saturday at ESC Congress 2023
News | Heart Failure
Trial of Ferric Carboxymaltose in Heart Failure Does Not Meet Primary Endpoint

August 28, 2023 — Ferric carboxymaltose(FCM) did not improve a hierarchical outcome of death, heart failure hospitalizat ...

Home August 28, 2023
Home
BUDAPEST CRT Upgrade trial presented in a Hot Line Session Saturday at ESC Congress 2023
News | Implantable Cardioverter Defibrillator (ICD)
Upgrade to Cardiac Resynchronization Therapy Benefits Heart Failure Patients with Pacing

August 28, 2023 — Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and ...

Home August 28, 2023
Home
STOPDAPT-3 trial presented in a Hot Line Session Saturday at ESC Congress 2023
News | Antiplatelet and Anticoagulation Therapies
Dual-antiplatelet Therapy Should Remain Standard Strategy After Stent Implantation

August 28, 2023 — Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not ...

Home August 28, 2023
Home
Videos | Pharmaceuticals
VIDEO, Part 1: Hypertrophic Cardiomyopathy: One on One with a Cardiovascular Research Leader

A 3-part video series with Christine E. Seidman, MD, FACC, FAHA


In the first of this 3-part “One on One” series, Dr ...

Home August 28, 2023
Home
Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced that its MyoVista wavECG has been selected by PanaceaFlo Ltd to be used in Dublin, Ireland in its heart screening evaluation study
News | Artificial Intelligence
HeartSciences’ MyoVista wavECG Selected to be used in Irish Heart Screening Evaluation

August 24, 2023 —Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical ...

Home August 24, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now